KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Inventory (2020 - 2025)

Organon (OGN) has 6 years of Inventory data on record, last reported at $1.4 billion in Q4 2025.

  • For Q4 2025, Inventory rose 6.43% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, up 6.43%, while the annual FY2025 figure was $1.4 billion, 6.43% up from the prior year.
  • Inventory reached $1.4 billion in Q4 2025 per OGN's latest filing, down from $1.5 billion in the prior quarter.
  • Across five years, Inventory topped out at $1.5 billion in Q3 2025 and bottomed at $871.0 million in Q2 2021.
  • Average Inventory over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2023.
  • Peak YoY movement for Inventory: dropped 4.25% in 2022, then soared 34.93% in 2023.
  • A 5-year view of Inventory shows it stood at $915.0 million in 2021, then grew by 9.62% to $1.0 billion in 2022, then soared by 31.11% to $1.3 billion in 2023, then rose by 0.46% to $1.3 billion in 2024, then increased by 6.43% to $1.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $1.4 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.5 billion in Q2 2025.